Leads Networking Pharmaceutical Pharmaceutical research 
Pharma Marketing Network
JULY 21, 2023
LinkedIn is a powerful tool that can help you connect with potential employers, clients, and other professionals in the pharmaceutical industry. But in order to get the most out of LinkedIn, you need to know a few tips and tricks that are specific to the pharmaceutical industry.
European Pharmaceutical Review
AUGUST 15, 2023
CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The Milan region is at the centre of Italy’s pharmaceutical base, with over 50 facilities in the Lombardy region alone.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Contrarian Sales Techniques
FEBRUARY 29, 2024
Are your interest piqued by the words ‘pharmaceutical sales’? Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. Internships: While less common than seeking full-time jobs, this could still be a possible intent.
PharmaKinnex
AUGUST 23, 2022
The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Primarily because of a fact that the pharmaceutical industry has known for some time—constant, honest, and meaningful communication with prescribers is lacking in the post-pandemic world. August 23, 2022. Why you may ask?
Pharma Marketing Network
JANUARY 26, 2022
Throughout her decades-long career, Seidenberg has transformed the lives of millions of patients by championing pharmaceutical research and development leading to the introduction of innovative life-saving products that treat diseases like AIDS, arthritis, asthma, cancer, and others.
Pharma Marketing Network
MAY 3, 2023
The pharmaceutical industry is a major contributor to the global economy, generating billions of dollars in revenue every year by developing and selling life-saving drugs. In particular, there are concerns that the pharmaceutical industry may be blocking treatments in order to increase profits, potentially putting millions of lives at risk.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5
Expert insights. Personalized for you.
52 
Let's personalize your content